FBXL15 Antibody - N-terminal region
Rabbit Polyclonal Antibody
- 产品详情
- 实验流程
- 背景知识
Application ![]()
| WB |
---|---|
Primary Accession | Q9H469 |
Other Accession | NM_024326, NP_077302 |
Reactivity | Human, Mouse, Rat, Rabbit, Dog, Horse, Bovine, Neisseria Gonorrhoeae |
Predicted | Human, Mouse, Rat, Rabbit, Dog, Horse, Bovine, Neisseria Gonorrhoeae |
Host | Rabbit |
Clonality | Polyclonal |
Calculated MW | 32998 Da |
Gene ID | 79176 |
---|---|
Alias Symbol | FBXO37, Fbl15, JET, PSD |
Other Names | F-box/LRR-repeat protein 15, F-box only protein 37, FBXL15, FBXO37 |
Format | Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
Reconstitution & Storage | Add 50 ul of distilled water. Final anti-FBXL15 antibody concentration is 1 mg/ml in PBS buffer with 2% sucrose. For longer periods of storage, store at 20°C. Avoid repeat freeze-thaw cycles. |
Precautions | FBXL15 Antibody - N-terminal region is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | FBXL15 |
---|---|
Synonyms | FBXO37 |
Function | Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of SMURF1, thereby acting as a positive regulator of the BMP signaling pathway. Required for dorsal/ventral pattern formation and bone mass maintenance. Also mediates ubiquitination of SMURF2 and WWP2. |
Cellular Location | Cytoplasm. |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Substrate recognition component of a SCF (SKP1-CUL1-F- box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of SMURF1, thereby acting as a positive regulator of the BMP signaling pathway. Required for dorsal/ventral pattern formation and bone mass maintenance. Also mediates ubiquitination of SMURF2 and WWP2.
REFERENCES
Deloukas P.,et al.Nature 429:375-381(2004).
Cui Y.,et al.EMBO J. 30:2675-2689(2011).
Van Damme P.,et al.Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.